Business & Finance J&J raises guidance for 2026 on strong start to the year
Johnson & Johnson said its pharmaceutical sales rose 11.2% in the first quarter of 2026.
By
· April 14, 2026 · 1 min read
This article was originally published by
MarketWatch
and is republished here under license.
Johnson & Johnson said its pharmaceutical sales rose 11.2% in the first quarter of 2026.
Like this:
Like Loading...
Related
The island province of Hainan has new marching orders.…
By
· April 28, 2026 · 1 min read
The S&P 500 and Nasdaq Composite closed at new record highs on Monday.…
By
· April 27, 2026 · 1 min read
Chinese EV stocks face a key test in upcoming results, which will offer clues for investors betting on the recently…
By
· April 27, 2026 · 1 min read
Leave a Reply